Standard Operating Procedure: Clinical Audit Execution

Standard Operating Procedure: Clinical Audit Execution & Verification

Template Registry Engineering & Compliance Directorate

---

1. Document Control Block

• Document ID: SOP-TR-CLIN-042
• Effective Date: October 24, 2023
• Version: 3.2.0
• Review Cadence: Semi-Annual (Every 6 Months)
• Owner: Chief Architect, Template Registry (Julian Vance)

---

2. Executive Summary & Purpose

This Standard Operating Procedure (SOP) defines the institutional-grade engineering lifecycle for designing, executing, and closing out clinical audits within the Template Registry ecosystem. The purpose of this protocol is to ensure absolute regulatory compliance, patient safety verification, and data integrity across all clinical operational workflows. By establishing a deterministic, repeatable verification checklist, this SOP eliminates procedural drift and guarantees alignment with GCP (Good Clinical Practice) and HIPAA/GDPR standards.

---

3. Scope & Prerequisites

3.1 Scope

This procedure applies to all clinical trials, retrospective chart reviews, and registry operations managed or ingested via Template Registry infrastructure. It governs internal audits, vendor oversight reviews, and pre-inspection readiness checks.

3.2 Required Tools, Software & Access

• Electronic Data Capture (EDC) System: Read-only auditor access with multi-factor authentication (MFA).
• Clinical Trial Management System (CTMS): Privileged access for tracking deviation logs and protocol amendments.
• Audit Management Suite: GRC (Governance, Risk, and Compliance) platform for non-conformance tracking.
• Hardware: Encrypted institutional workstation running a FIPS 140-2 validated OS.
• Personal Protective Equipment (PPE): Not applicable for digital/desktop review; standard institutional visitor protocols apply if physical site access is required.

---

4. Roles & Responsibilities (RACI Matrix)

• RACI Definitions: Responsible (does the work), Accountable (owns the outcome), Consulted (provides input), Informed (kept updated).

---

5. Step-by-Step Procedure

Phase 1: Pre-Audit Preparation & Scope Definition

• 1.1 Review the approved clinical protocol, Statistical Analysis Plan (SAP), and prior audit reports in the GRC platform.
• 1.2 Define the audit scope (e.g., 100% source data verification vs. targeted sampling of primary endpoint data).
• 1.3 Generate and validate the randomized subject selection list using cryptographically secure methods.
• 1.4 Coordinate with the Principal Investigator (PI) and Site Data Coordinator to establish secure access channels and scheduling.
• 1.5 Distribute the formal Audit Notification Letter at least 14 business days prior to execution.

Phase 2: Documentation & Regulatory Compliance Verification

• 2.1 Verify the current, IRB-approved version of the protocol and informed consent forms (ICFs) are actively deployed.
• 2.2 Inspect the Delegation of Authority (DoA) log to ensure all site staff training records are current and signed prior to task execution.
• 2.3 Cross-reference Investigator Financial Disclosure forms against active study personnel.
• 2.4 Verify Investigational Product (IP) accountability logs for chain of custody, storage temperature compliance, and dispensing accuracy.
• 2.5 Confirm Laboratory Certifications (CLIA/CAP) and normal value ranges are up-to-date and filed in the Investigator Site File (ISF).

Phase 3: Source Data Verification (SDV) & System Integrity

• 3.1 Perform SDV on a statistically significant sample of patient records, matching EDC entries against physical or electronic source documents (EMR/EHR).
• 3.2 Validate the 100% reconciliation of Serious Adverse Events (SAEs) reported in the EDC against hospital discharge summaries and safety databases.
• 3.3 Check query management logs for unresolved queries older than 14 calendar days.
• 3.4 Verify audit trails within the EDC for unauthorized data overrides, backdating, or missing change-reason documentation.
• 3.5 Assess protocol deviation logs for completeness, root-cause analysis, and timely reporting to the IRB/Sponsor.

Phase 4: Reporting, Debriefing & Remediation

• 4.1 Compile identified discrepancies into the preliminary Audit Finding Report, categorizing them by severity (Critical, Major, Minor).
• 4.2 Conduct an exit debriefing with the PI and key site personnel to present preliminary findings and clarify factual discrepancies.
• 4.3 Issue the formal Audit Report to the QA Compliance Officer and Chief Architect within 5 business days of audit completion.
• 4.4 Require the site to submit a Corrective and Preventive Action (CAPA) plan within 15 business days of receiving the final report.
• 4.5 Verify CAPA implementation and document closure in the Template Registry GRC system.

---

6. Quality Assurance & Pro-Tips

6.1 Best Practices

• Traceability is Paramount: Ensure every finding links directly to a specific regulatory citation (e.g., 21 CFR Part 11, ICH GCP E6(R2)) or protocol section.
• Maintain Professional Skepticism: Treat missing data or delayed query responses as high-priority risk indicators until proven otherwise.
• Immutable Logging: Never alter raw audit notes; append addendums with timestamped justifications if context changes.

6.2 Common Pitfalls to Avoid

• Scope Creep: Do not expand the audit into unapproved subject cohorts without explicit sign-off from the Chief Architect.
• Premature Closure: Closing an audit finding before verifying the operational effectiveness of the implemented CAPA.

6.3 Metric Thresholds

• Critical Findings Tolerance: 0 (Any critical finding triggers immediate operational suspension of the site).
• Query Resolution Rate: $\ge 95%$ of queries resolved within the standard 14-day window.
• CAPA Submission Timeliness: $\le 15$ business days from report issuance.

---

7. Frequently Asked Questions (FAQ)

Q1: What triggers an immediate escalation to a "Critical Finding" classification?
A: Any breach of patient safety, falsification of data, missing Informed Consent Documentation for enrolled subjects, or unapproved protocol modifications that directly endanger participant welfare automatically constitutes a Critical Finding.

Q2: How should an auditor handle system access revocations or unexpected downtime during remote SDV?
A: Immediately halt the session, log the exact timestamp and error code, notify the Site Data Coordinator and IT Security Desk, and document the interruption in the audit trail log. Reschedule the remainder of the verification session once access is restored and verified.

Q3: Can minor documentation errors be corrected during the audit execution phase?
A: No. Auditors must not alter site data or prompt staff to fix errors while the audit is active. All discrepancies must be logged as findings, allowing the site to remediate them via standard data management or CAPA workflows post-audit.